پگفیلگراستیم (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "پگفیلگراستیم" in Persian language version.

refsWebsite

Global rank Persian rank

10web.archive.org

1^st place

1^st place

68^th place

179^th place

399^th place

104^th place

2medicines.org.uk

3,823^rd place

1,188^th place

3,984^th place

1,143^rd place

low place

low place

4^th place

5^th place

447^th place

382^nd place

low place

low place

cinnagen.com

«سیناژن: پگاژن». www.cinnagen.com. دریافت‌شده در ۲۰۲۲-۰۸-۲۶.

drugs.com

"Pegfilgrastim Use During Pregnancy". Drugs.com. 9 December 2019. Archived from the original on 5 December 2020. Retrieved 13 July 2020.
"Pegfilgrastim Monograph for Professionals". Drugs.com. 22 August 2019. Archived from the original on 7 March 2016. Retrieved 11 June 2020.

europa.eu

ema.europa.eu

"Ziextenzo EPAR". آژانس دارویی اروپا (EMA). Archived from the original on 11 June 2020. Retrieved 2 April 2020.
"Neulasta EPAR". آژانس دارویی اروپا (EMA). Archived from the original on 11 June 2020. Retrieved 2 April 2020.

fda.gov

accessdata.fda.gov

"Drug Approval Package: Neulasta (Pegfilgrastim) NDA #125031". U.S. سازمان غذا و دارو (آمریکا) (FDA). 25 October 2004. Archived from the original on 30 March 2021. Retrieved 11 June 2020.

hres.ca

hpr-rps.hres.ca

"Summary Basis of Decision (SBD) for Ziextenzo". Health Canada. 23 October 2014. Archived from the original on 30 May 2022. Retrieved 29 May 2022.

medicines.org.uk

"Neulasta Pre-Filled Syringe - Summary of Product Characteristics (SmPC)". (emc). 1 June 2021. Archived from the original on 15 January 2021. Retrieved 11 October 2021.
"Neulasta On Body Injector - Summary of Product Characteristics (SmPC)". (emc). Archived from the original on 17 January 2021. Retrieved 11 October 2021.

nih.gov

dailymed.nlm.nih.gov

"Neulasta- pegfilgrastim kit Neulasta- pegfilgrastim injection". DailyMed. Archived from the original on 15 July 2021. Retrieved 14 July 2021.

tga.gov.au

tga.gov.au

"Ziextenzo". Therapeutic Goods Administration (TGA). 13 December 2019. Archived from the original on 20 October 2021. Retrieved 25 August 2020.

ebs.tga.gov.au

"Summary for ARTG Entry: 82873 Neulasta pegfilgrastim rbe 6mg/0.6mL injection syringe with stelmi needle shield" (PDF). Therapeutic Goods Administration (TGA).^{^{[پیوند مرده]}}

web.archive.org

"Ziextenzo EPAR". آژانس دارویی اروپا (EMA). Archived from the original on 11 June 2020. Retrieved 2 April 2020.
"Summary Basis of Decision (SBD) for Ziextenzo". Health Canada. 23 October 2014. Archived from the original on 30 May 2022. Retrieved 29 May 2022.
"Ziextenzo". Therapeutic Goods Administration (TGA). 13 December 2019. Archived from the original on 20 October 2021. Retrieved 25 August 2020.
"Pegfilgrastim Use During Pregnancy". Drugs.com. 9 December 2019. Archived from the original on 5 December 2020. Retrieved 13 July 2020.
"Neulasta Pre-Filled Syringe - Summary of Product Characteristics (SmPC)". (emc). 1 June 2021. Archived from the original on 15 January 2021. Retrieved 11 October 2021.
"Neulasta On Body Injector - Summary of Product Characteristics (SmPC)". (emc). Archived from the original on 17 January 2021. Retrieved 11 October 2021.
"Neulasta- pegfilgrastim kit Neulasta- pegfilgrastim injection". DailyMed. Archived from the original on 15 July 2021. Retrieved 14 July 2021.
"Neulasta EPAR". آژانس دارویی اروپا (EMA). Archived from the original on 11 June 2020. Retrieved 2 April 2020.
"Drug Approval Package: Neulasta (Pegfilgrastim) NDA #125031". U.S. سازمان غذا و دارو (آمریکا) (FDA). 25 October 2004. Archived from the original on 30 March 2021. Retrieved 11 June 2020.
"Pegfilgrastim Monograph for Professionals". Drugs.com. 22 August 2019. Archived from the original on 7 March 2016. Retrieved 11 June 2020.